arrow
H

Hillary W. Garner

Mayo Clinic
H指数:17
被引数:1,228

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing Radiography Utilization: Multidisciplinary Expert Consensus Recommendations Endorsed by the Society of Academic Bone Radiologists, Society of SkeletalRadiology, American Society of Emergency Radiology, Orthopaedic Trauma Association, American Academy of Emergency Medicine, and American Rhinologic Society

优化放射学应用:由学术骨放射学会、骨骼放射学会、美国急诊放射学会、骨科创伤协会、美国急诊医学学会和美国鼻科学会共同支持的多学科专家共识建议

Radiology
IF15.2
2026-05-010
PRE
MRI findings for differentiating benign and malignant soft tissue tumors: a systematic review-part 2: key imaging findings

MRI检查在鉴别良性及恶性软组织肿瘤中的诊断价值:系统综述第二部分:关键影像学表现

2026-02-010
OA
MRI findings for differentiating benign and malignant soft tissue tumors: a narrative review- Part 1: diagnostic performance

MRI检查在区分良性及恶性软组织肿瘤中的发现:一项叙事综述- 第一部分:诊断效能

2026-01-010
OA
ACR Appropriateness Criteria® Suspected Osteomyelitis of the Foot in Patients With Diabetes Mellitus: 2025 Update

ACR Appropriateness Criteria® 糖尿病患者足部疑似骨髓炎:2025年更新

2025-11-030
PRE
Associations Between Deep Learning-Derived Fat, Muscle, and Bone Measures From Abdominal Computed Tomography Scans and Fall Risk in Persons Aged 20 Years or Older

基于腹部计算机断层扫描的深度学习衍生脂肪、肌肉和骨骼测量值与20岁及以上人群跌倒风险之间的关联

2025-11-010
OA
Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality

来自腹部计算机断层扫描的肌肉,脂肪和骨骼生物标志物的老年组织年龄与慢性病和较高的死亡率有关

2024-06-014
PRE
Abdominal Body Composition Reference Ranges and Association With Chronic Conditions in an Age- and Sex-Stratified Representative Sample of a Geographically Defined American Population

在地理定义的美国人口的年龄和性别分层代表性样本中,腹部身体成分参考范围及其与慢性病的关联

2024-02-192
OAAI
Creating High Fidelity Synthetic Pelvis Radiographs Using Generative Adversarial Networks: Unlocking the Potential of Deep Learning Models Without Patient Privacy Concerns

使用生成对抗网络创建高保真度合成骨盆射线照片: 释放深度学习模型的潜力,无需患者隐私问题

2023-10-0117
OAAI
ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update
2022-11-015
PRE